文献速递肺栓塞与肺血管病间质性肺疾病

1型神经纤维瘤病相关肺动脉高压的表型与结局

Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

基于法国肺动脉高压注册队列,报告49例1型神经纤维瘤病相关肺动脉高压(PH-NF1)患者的临床、功能、影像、病理及血流动力学特征。患者以女性为主,诊断时中位年龄62岁,表现为低DlCO、严重低氧血症和严重毛细血管前性肺动脉高压,接受PAH药物治疗后功能分级与血流动力学改善,但无移植生存率仍低。

要点

  • PH-NF1以女性为主,诊断时多为NYHA功能III或IV级,DlCO低且低氧血症严重。
  • 右心导管示严重毛细血管前性肺动脉高压,PAH药物可改善功能分级与血流动力学。
  • 无移植生存率1年87%、3年54%、5年42%,符合条件者可考虑双肺移植。

核心结论

  • PH-NF1以女性 predominance、低DlCO及严重功能与血流动力学损害为特征,尽管PAH治疗可能有获益,预后仍差,双肺移植是合适患者的选择。

研究设计与样本

  • 来自法国肺动脉高压注册队列的PH-NF1病例系列,共49例,收集临床、功能、影像、病理及血流动力学资料并分析PAH药物反应与无移植生存。
  • 女性/男性比为3.9,诊断时中位(最小-最大)年龄为62(18-82)岁。

主要发现

  • 诊断时92%为NYHA功能III或IV级,6分钟步行距离为211(0-460)m。
  • 肺功能示低DlCO(30%[12-79%])和严重低氧血症(PaO2 56[38-99] mm Hg)。
  • 右心导管示严重毛细血管前性肺动脉高压,平均肺动脉压45(10)mm Hg,肺血管阻力10.7(4.2)Wood单位。
  • 高分辨率CT示囊肿76%、磨玻璃影73%、肺气肿49%、网格影39%。

关键数值与推荐

  • PH-NF1诊断时92%为NYHA功能III或IV级。
  • 6分钟步行距离211(0-460)m。
  • DlCO 30%(12-79%),PaO2 56(38-99)mm Hg。
  • 平均肺动脉压45(10)mm Hg,肺血管阻力10.7(4.2)Wood单位。
  • 1、3、5年无移植生存率分别为87%、54%、42%。

临床怎么用

  • 对NF1患者出现呼吸困难或低氧血症时应警惕PH-NF1,完善DlCO、右心导管和HRCT评估。
  • PAH获批药物可考虑用于PH-NF1以改善功能分级和血流动力学,但需认识预后仍差。
  • 符合条件者应评估双肺移植指征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Pulmonary hypertension (PH) associated with neurofibromatosis type 1 (NF1) is a rare and largely unknown complication of NF1.Objectives: To describe characteristics and outcomes of PH-NF1.Methods: We reported the clinical, functional, radiologic, histologic, and hemodynamic characteristics, response to pulmonary arterial hypertension (PAH)-approved drugs, and transplant-free survival of patients with PH-NF1 from the French PH registry.Measurements and Main Results: We identified 49 PH-NF1 cases, characterized by a female/male ratio of 3.9 and a median (minimum-maximum) age at diagnosis of 62 (18-82) years. At diagnosis, 92% were in New York Heart Association functional class III or IV. The 6-minute-walk distance was 211 (0-460) m. Pulmonary function tests showed low DlCO (30% [12-79%]) and severe hypoxemia (PaO2 56 [38-99] mm Hg). Right heart catheterization showed severe precapillary PH with a mean pulmonary artery pressure of 45 (10) mm Hg and a pulmonary vascular resistance of 10.7 (4.2) Wood units. High-resolution computed tomography images revealed cysts (76%), ground-glass opacities (73%), emphysema (49%), and reticulations (39%). Forty patients received PAH-approved drugs with a significant improvement in functional class and hemodynamic parameters. Transplant-free survival at 1, 3, and 5 years was 87%, 54%, and 42%, respectively, and four patients were transplanted. Pathologic assessment showed nonspecific interstitial pneumonia and major pulmonary vascular remodeling.Conclusions: PH-NF1 is characterized by a female predominance, a low DlCO, and severe functional and hemodynamic impairment. Despite a potential benefit of PAH treatment, prognosis remains poor, and double-lung transplantation is an option for eligible patients.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Jutant EM, Jaïs X, Girerd B, et al. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1. Am J Respir Crit Care Med. 2020. PMID: 32437637. doi:10.1164/rccm.202001-0105OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。